DK0804182T3 - Anvendelse af gabapentin ved behandling af angst og panik - Google Patents
Anvendelse af gabapentin ved behandling af angst og panikInfo
- Publication number
- DK0804182T3 DK0804182T3 DK95926249T DK95926249T DK0804182T3 DK 0804182 T3 DK0804182 T3 DK 0804182T3 DK 95926249 T DK95926249 T DK 95926249T DK 95926249 T DK95926249 T DK 95926249T DK 0804182 T3 DK0804182 T3 DK 0804182T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- gabapentin
- anxiety
- panic
- terminal sequence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28128594A | 1994-07-27 | 1994-07-27 | |
US08/445,398 US5792796A (en) | 1994-07-27 | 1995-06-06 | Methods for treating anxiety and panic |
PCT/US1995/008702 WO1996003122A2 (en) | 1994-07-27 | 1995-07-11 | Use of gabapentin in the treatment of anxiety and panic |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0804182T3 true DK0804182T3 (da) | 2002-09-09 |
Family
ID=26960801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95926249T DK0804182T3 (da) | 1994-07-27 | 1995-07-11 | Anvendelse af gabapentin ved behandling af angst og panik |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0804182B1 (es) |
JP (1) | JPH10503490A (es) |
AT (1) | ATE218334T1 (es) |
AU (1) | AU703428B2 (es) |
CA (1) | CA2193384C (es) |
CZ (1) | CZ291757B6 (es) |
DE (1) | DE69526972T2 (es) |
DK (1) | DK0804182T3 (es) |
ES (1) | ES2176334T3 (es) |
HU (4) | HU0102041D0 (es) |
MX (1) | MX9606674A (es) |
NZ (1) | NZ290050A (es) |
PL (1) | PL187064B1 (es) |
PT (1) | PT804182E (es) |
RO (1) | RO120041B1 (es) |
RU (1) | RU2168982C2 (es) |
SK (1) | SK283711B6 (es) |
WO (1) | WO1996003122A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5712158A (en) * | 1995-06-06 | 1998-01-27 | Warner-Lambert Company | Cell line for the rapid expression of functional calcium channels |
US6372792B1 (en) | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
CN1094757C (zh) | 1996-07-24 | 2002-11-27 | 沃尼尔·朗伯公司 | 用于治疗疼痛的异丁基γ-氨基丁酸及其衍生物 |
PL199794B1 (pl) | 1997-10-27 | 2008-10-31 | Warner Lambert Co | Związki pośrednie do wytwarzania pochodnych cyklicznych aminokwasów |
JP2002516312A (ja) * | 1998-05-26 | 2002-06-04 | ワーナー−ランバート・カンパニー | カルシウムチャンネルのα2δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物 |
FR2781793B1 (fr) * | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
CA2384911C (en) * | 1999-09-16 | 2008-07-22 | Warner-Lambert Company | Method for the screening of .alpha.2. delta.-1 subunit binding ligands |
RU2377234C2 (ru) * | 2003-09-17 | 2009-12-27 | Ксенопорт, Инк. | Лечение или предупреждение синдрома беспокойных ног с использованием пролекарств аналогов гамк |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2016465A1 (en) * | 1989-06-02 | 1990-12-02 | Zola Phillip Horovitz | Method for preventing or treating anxiety employing a calcium channel blocker |
US5189026A (en) * | 1991-06-07 | 1993-02-23 | Fractal Laboratories, Inc. | Treatment of human diseases involving dysregulation or dysfunction of the nervous system |
EP0641330B1 (en) * | 1992-05-20 | 2001-10-17 | Northwestern University | Gaba and l-glutamic acid analogs for antiseizure treatment |
-
1995
- 1995-07-11 NZ NZ290050A patent/NZ290050A/xx unknown
- 1995-07-11 ES ES95926249T patent/ES2176334T3/es not_active Expired - Lifetime
- 1995-07-11 PT PT95926249T patent/PT804182E/pt unknown
- 1995-07-11 CZ CZ1997162A patent/CZ291757B6/cs not_active IP Right Cessation
- 1995-07-11 AU AU30069/95A patent/AU703428B2/en not_active Ceased
- 1995-07-11 RU RU97101109/14A patent/RU2168982C2/ru not_active IP Right Cessation
- 1995-07-11 JP JP8505766A patent/JPH10503490A/ja not_active Ceased
- 1995-07-11 WO PCT/US1995/008702 patent/WO1996003122A2/en active IP Right Grant
- 1995-07-11 DK DK95926249T patent/DK0804182T3/da active
- 1995-07-11 RO RO97-00128A patent/RO120041B1/ro unknown
- 1995-07-11 HU HU0102041A patent/HU0102041D0/hu unknown
- 1995-07-11 MX MX9606674A patent/MX9606674A/es active IP Right Grant
- 1995-07-11 CA CA002193384A patent/CA2193384C/en not_active Expired - Fee Related
- 1995-07-11 HU HU9700238A patent/HU223841B1/hu not_active IP Right Cessation
- 1995-07-11 AT AT95926249T patent/ATE218334T1/de not_active IP Right Cessation
- 1995-07-11 HU HU0102040A patent/HU0102040D0/hu unknown
- 1995-07-11 DE DE69526972T patent/DE69526972T2/de not_active Expired - Fee Related
- 1995-07-11 EP EP95926249A patent/EP0804182B1/en not_active Expired - Lifetime
- 1995-07-11 HU HU0102043A patent/HU0102043D0/hu unknown
- 1995-07-11 SK SK90-97A patent/SK283711B6/sk unknown
- 1995-07-11 PL PL95318268A patent/PL187064B1/pl not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU0102041D0 (en) | 2001-07-30 |
AU3006995A (en) | 1996-02-22 |
JPH10503490A (ja) | 1998-03-31 |
AU703428B2 (en) | 1999-03-25 |
ES2176334T3 (es) | 2002-12-01 |
SK283711B6 (sk) | 2003-12-02 |
CA2193384A1 (en) | 1996-02-08 |
CZ291757B6 (cs) | 2003-05-14 |
HU223841B1 (hu) | 2005-02-28 |
HU0102043D0 (en) | 2001-07-30 |
MX9606674A (es) | 1997-03-29 |
SK9097A3 (en) | 1998-05-06 |
NZ290050A (en) | 1999-08-30 |
EP0804182B1 (en) | 2002-06-05 |
CA2193384C (en) | 2002-03-19 |
PL318268A1 (en) | 1997-05-26 |
PT804182E (pt) | 2002-10-31 |
DE69526972D1 (de) | 2002-07-11 |
WO1996003122A3 (en) | 1996-07-18 |
RO120041B1 (ro) | 2005-08-30 |
RU2168982C2 (ru) | 2001-06-20 |
PL187064B1 (pl) | 2004-05-31 |
WO1996003122A2 (en) | 1996-02-08 |
DE69526972T2 (de) | 2002-11-21 |
CZ16297A3 (en) | 1997-07-16 |
ATE218334T1 (de) | 2002-06-15 |
HU0102040D0 (en) | 2001-07-30 |
EP0804182A2 (en) | 1997-11-05 |
HUT76835A (en) | 1997-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200000652A1 (ru) | Кристаллы глюкагоноподобного пептида 1 | |
ATE245416T1 (de) | Neue fettanaloge zur behandlung von diabetes | |
BG102619A (en) | Substituted n-[(aminoiminomethyl or aminomethyl) phenyl] propylamides | |
DE69027865D1 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
DE69837324D1 (de) | Behandlung der multiplen sklerose durch einnahme von copolymer-1 | |
DK0804182T3 (da) | Anvendelse af gabapentin ved behandling af angst og panik | |
NO955067D0 (no) | FVII/TF peptider | |
ES548052A0 (es) | Procedimiento para preparar peptidos | |
MXPA02004505A (es) | Peptidos mimeticos para epitope de apolipoproteinab-100 concatamero y peptidos modificados del mismo, y la composicion de vacuna que comprende los mismos. | |
EA200100314A1 (ru) | Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины | |
DE69529235D1 (de) | Menschliche dnase i varianten | |
ATE179989T1 (de) | Peptide zur behandlung von allergien | |
DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it | |
WO1998029436A3 (en) | Lebetin peptides as platelet aggregation inhibitors |